Alan G Wade

Summary

Publications

  1. ncbi Baseline characteristics and patient reported outcome data of patients prescribed etanercept: web-based and telephone evaluation
    Alan G Wade
    Patients Direct, Glasgow, UK
    BMC Med Res Methodol 11:91. 2011
  2. ncbi Patient reported outcome data following influenza A (H1N1p) vaccination in the 2009-2010 season: web-based and telephone evaluation
    Alan G Wade
    Patients Direct, 3 Todd Campus, Glasgow, UK
    Ther Clin Risk Manag 7:409-20. 2011
  3. ncbi Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety
    Alan G Wade
    CPS Research, Glasgow, UK
    BMC Med 8:51. 2010
  4. ncbi A multicentre, randomised, double-blind, single-dose study assessing the efficacy of AMC/DCBA Warm lozenge or AMC/DCBA Cool lozenge in the relief of acute sore throat
    Alan G Wade
    CPS Research, Glasgow, UK
    BMC Fam Pract 12:6. 2011
  5. ncbi Efficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot study
    Alan G Wade
    CPS Research, Glasgow, G20 0XA, UK
    BMC Psychiatry 11:42. 2011
  6. ncbi A survey of patient preferences for a placebo orodispersible tablet
    Alan G Wade
    CPS Research, Glasgow, UK
    Patient Prefer Adherence 6:201-6. 2012

Collaborators

Detail Information

Publications6

  1. ncbi Baseline characteristics and patient reported outcome data of patients prescribed etanercept: web-based and telephone evaluation
    Alan G Wade
    Patients Direct, Glasgow, UK
    BMC Med Res Methodol 11:91. 2011
    ..This manuscript describes the self-reported baseline characteristics and health-related quality of life of patients prior to treatment. Follow-up data will be reported separately...
  2. ncbi Patient reported outcome data following influenza A (H1N1p) vaccination in the 2009-2010 season: web-based and telephone evaluation
    Alan G Wade
    Patients Direct, 3 Todd Campus, Glasgow, UK
    Ther Clin Risk Manag 7:409-20. 2011
    ..This evaluation was designed to collect data from people who had received an influenza vaccination during the 2009-2010 season using a web-based data collection tool supplemented by telephone reporting (PROBE)...
  3. ncbi Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety
    Alan G Wade
    CPS Research, Glasgow, UK
    BMC Med 8:51. 2010
    ....
  4. ncbi A multicentre, randomised, double-blind, single-dose study assessing the efficacy of AMC/DCBA Warm lozenge or AMC/DCBA Cool lozenge in the relief of acute sore throat
    Alan G Wade
    CPS Research, Glasgow, UK
    BMC Fam Pract 12:6. 2011
    ....
  5. ncbi Efficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot study
    Alan G Wade
    CPS Research, Glasgow, G20 0XA, UK
    BMC Psychiatry 11:42. 2011
    ..Escitalopram is licensed for use at doses up to 20 mg but is used clinically at higher doses. There is limited published data at higher doses and none in the treatment of Major Depressive Disorder (MDD)...
  6. ncbi A survey of patient preferences for a placebo orodispersible tablet
    Alan G Wade
    CPS Research, Glasgow, UK
    Patient Prefer Adherence 6:201-6. 2012
    ..To assess the attitudes and preferences of patients currently being treated for depression or anxiety disorders with traditional oral antidepressants relative to a placebo orodispersible (ODT) formulation of escitalopram...